NYSE · OSH
Healthcare · Medical - Care Facilities
$39.00
Up+$0.03 (+0.08%)
Updated Aug 14, 2026, 1:10 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
OSH does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning OSH.
OSH research
Company profile and research snapshot.
Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 21, 2023 | Wolfe Research | Peer Perform | — |
| Mar 15, 2023 | TD Cowen | Market Perform | — |
| Feb 23, 2023 | JP Morgan | Neutral | — |
| Feb 15, 2023 | Bernstein | Market Perform | — |
| Feb 10, 2023 | Raymond James | Market Perform | — |
No generated briefing is available yet.
Zacks Investment Research · Apr 27, 2023
Encompass Health (EHC) delivered earnings and revenue surprises of 25.71% and 1.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Benzinga · Apr 21, 2023
As a part of a broader coverage of 15 companies in the Healthcare Services sector, Cantor Fitzgerald initiated coverage on CVS Health Corp (NYSE: CVS) with a price target of $87 and an Overweight rating. Once pieced together, CVS, Signify Health, Oak Street Health Inc (NYSE: OSH), and Carbon (JV) can create a flywheel that brings in industry-leading, consumer-facing technology and ease of access, enhanced brand value across commercial and Medicare, higher NPS (net ...Full story available on Benzinga.com
The Motley Fool · Apr 18, 2023
Putting some shares of this dividend growth stock in your portfolio now could lead to heaps of passive income during your retirement years.
Benzinga · Mar 31, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Palisade Bio, Inc. (NASDAQ: PALI) Palisade Bio reported year end 2022 financial results and issued corporate update. “Our team has made great progress executing our operational plan to strengthen our financial profile, focus our pipeline and position the Company for important near-term data readouts. With the cash proceeds from ...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning OSH.
No results
No recent SID articles mention OSH.
